Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Employees - 104900,
CEO - Ms. Gail Koziara Boudreaux,
Sector - Healthcare,
Country - US,
Market Cap - 84.75B
Altman ZScore(max is 10): 3.09, Piotroski Score(max is 10): 6, Working Capital: $20813000000, Total Assets: $116533000000, Retained Earnings: $35157000000, EBIT: 9403000000, Total Liabilities: $72654000000, Revenue: $174015000000
- Current Price $365.96 - Analyst Target Price $496.61| Ticker | ELV |
| Index | S&P 500 |
| Curent Price | 365.96 |
| Change | -0.14% |
| Market Cap | 84.75B |
| Average Volume | 1.94M |
| Income | 6.42B |
| Sales | 174.01B |
| Book Value/Share | 188.74 |
| Cash/Share | - |
| Dividend Est | 6.33 (1.73%) |
| Dividend TTM | 6.52 (1.78%) |
| Dividend Ex-Date | Dec 05, 2024 |
| Employees | 104900 |
| Moving Avg 20days | -5.98% |
| Moving Avg 50days | -11.09% |
| Moving Avg 200days | -26.61% |
| Shares Outstanding | 231.93M |
| Earnings Date | Oct 17 BMO |
| Inst. Ownership | 90.41% |
| Price/Earnings | 13.34 |
| Forwad P/E | 10.48 |
| PE Growth | 1.48 |
| Price/Sales | 0.49 |
| Price/Book | 1.94 |
| Price/Cash | - |
| Price/FCF | 97.31 |
| Quick Ratio | - |
| Current Ratio | 1.50 |
| Debt/Equity | 0.62 |
| Return on Assets | 5.65% |
| Return on Equity | 15.62% |
| Return on Investment | 9.37% |
| Gross Margin | - |
| Ops Margin | 5.29% |
| Profit Margin | 3.69% |
| RSI | 28.86 |
| BETA(β) | 0.85 |
| From 52week Low | 1.04% |
| From 52week High | -35.49% |
| EPS | 27.43 |
| EPS next Year | 34.91 |
| EPS next Qtr | 3.98 |
| EPS this Year | 0.12% |
| EPS next 5 Year | 9.01% |
| EPS past 5 Year | 12.18% |
| Sales past 5 Year | 13.24% |
| EPS Y/Y | 7.55% |
| Sales Y/Y | 3.20% |
| EPS Q/Q | -20.03% |
| Sales Q/Q | 5.36% |
| Sales Surprise | 2.88% |
| EPS Surprise | -13.33% |
| ATR(14) | 10.29 |
| Perf Week | -4.05% |
| Perf Month | -7.93% |
| Perf Quarter | -31.46% |
| Perf Year | -20.31% |
| Perf YTD | -22.39% |
| Target Price | 496.61 |
AryaFin Engine© - An AI FinTech Venture - 2024 Disclaimer